Clinical Trial Update: Ixekizumab Diabetes Intervention Trial (I-DIT) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating ixekizumab for Type 1 diabetes mellitus is currently recruiting (I-DIT).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Ixekizumab (ixekizumab)

Snippet

Sponsor: Göteborg University | Conditions: Type1 Diabetes Mellitus | Phase 2 | Status: RECRUITING